GB2069498A - Substituted- tetrahydroquinaldines, intermediates for 6,7-dihydro-9- fluoro-5-methyl-1-oxo-1H,5H- benzo(ij)quinolizine-2-carboxylic Acid - Google Patents
Substituted- tetrahydroquinaldines, intermediates for 6,7-dihydro-9- fluoro-5-methyl-1-oxo-1H,5H- benzo(ij)quinolizine-2-carboxylic Acid Download PDFInfo
- Publication number
- GB2069498A GB2069498A GB8105054A GB8105054A GB2069498A GB 2069498 A GB2069498 A GB 2069498A GB 8105054 A GB8105054 A GB 8105054A GB 8105054 A GB8105054 A GB 8105054A GB 2069498 A GB2069498 A GB 2069498A
- Authority
- GB
- United Kingdom
- Prior art keywords
- crotonaldehyde
- acid
- mixture
- compound
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compounds of the formula: <IMAGE> wherein R is hydrogen or alkyl having 1-3 carbon atoms, and acid addition salts thereof, are useful intermediates in the preparation of 6- fluorotetrahydroquinaldine and flumequine which has the formula: <IMAGE>
Description
SPECIFICATION
Process and Intermediates for 6,7-dihydro-9fluoro-5-methyl-1 -oxo-1 H,5Hbenzo(ij)quinolizine-2-carboxylic Acid
This invention relates to an improved process for the preparation of 6,7-dihydro-9-fluoro-5 methyl-1-oxo-1 H,5H-benzo[ij]quinolizine-2carboxylic acid (flumequine) and intermediates therefor starting with 4-fluoroaniline.
Flumequine is a known antimicrobial compound described and claimed in United
States Patent No. 3,896,131 (Example 3). The starting material for the process described in that patent is 6-fl uoro-2-methyl-tetrahydroquinoline (6-fluorotetrahydroquinaldine). 6-Fluorotetrahydroquinaldine is prepared from 6fluoroquinaldine, a compound first described by
Mirek (Chem. Abs. 62, 5252, 1965), by routine chemical or catalytic reduction procedures. The
Mirek process for preparing 6-fluoroquinaldine involves treating 4-fluoroaniline with concentrated acid, zinc chloride and paraldehyde.
The mixture is left at ambient temperature for two hours, followed by boiling, alkalization and steam distillation. The distillate is extracted with benzene, dried and the solvent removed. The residue is distilled in vacuo and dissolved in concentrated hydrochloric acid in water. The solution is treated with zinc chloride in hydrochloric acid and cooled. The precipitate is washed with cold hydrochoric acid, dissociated with concentrated sodium hydroxide and steam distilled to prepare 6-fluoro-quinaldine. The yield of 6-fluoroquinaldine from the Mirek process is reported to be only 36.9%. When the 6fluoroquinaldine is reduced to 6fluorotetrahydroquinaldine in order to prepare flumequine an even further reduction in overall yield results.
The process of the present invention is a marked improvement over the prior art process. It results in significantly higher yields of 6fluorotetrahydroquinaldine in the range of 70 to 80 percent. Furthermore, it offers various practical advantages including a reduction in the number of reagents and the number and difficulty of operation steps.
The present invention provides a process for preparing the compound 6,7-dihydro-9-fluoro-5 methyl-i -oxo-1 H,5H-benzo[ij]quinolizine-2- carboxylic acid (flumequine) of Formula I
which comprises:
1) reacting 4-fluoroaniline with crotonaldehyde, or a precursor for crotonaldehyde which generates crotonaldehyde under the acidic conditions of the reaction such as acetaldehyde, acetal or paraldehyde, optionally in an alcoholic solution, in the presence of dilute aqueous acid such as hydrochloric acid at a temperature between about 50 and 600C to provide the compound
wherein R is hydrogen or alkyl having one, two or three carbon atoms, as e.g., the acid addition salts;
2) heating the product of step 1) to provide a mixture of 6-fluoro-quinaldine and 6fluorotetrahydroquinaldine as the acid salts;;
3) treating the acid salts with base in the presence of weak acid followed by reducing the mixture to provide 6-fluorotetrahydro-quinaldine, optionally purified as the acid salt;
4) condensing with a dialkyl alkoxymethylenemalonate (alkyl meaning one to three carbon atoms) such as the diethyl ester to provide the compound
5) cyclizing by heating in the presence of polyphosphoric acid then saponifying to provide flumequine.
The novel intermediates of the invention are the compounds of Formula II, with compounds wherein R is hydrogen or methyl, especially as the hydrochloride salt, being preferred.
The essence of the invention lies in the first two steps of the process which are responsible for the significant increase in overall yield. In the first step of the preferred embodiment of the process, a slight e.g., 5% molar excess of an aqueous alcoholic (preferably aqueous methanolic) solution of crotonaldehyde is added to a mixture of 4-fluoroaniline and dilute hydrochloric acid.
Paraldehyde can be used, but the yields and purity of the product are both poorer. Other reactants such as acetaldehyde, acetal and the like which are crotonaldehyde precursors under acidic reaction conditions may also be used. Pure crotonaldehyde or an aqueous solution of crotonaldehyde (e.g. 85%) can be used, but an aqueous alcoholic solution is preferred to maintain reaction homogeneity and increase yield. The ratio of methanol to 85% crotonaldehyde solution is about 1 ml per gram.
The rate of addition of the aldehyde appears to have some effect on yield. Slow addition provides better yields of product. The rate of addition is somewhat easier to control using a solution of crotonaldehyde. In a 40 mole scale run, addition is desirably carried out over about 8 hours at a temperature of between about 50 and 600C and preferably at about 550C. Careful control of temperature is very important since significant deviations from this temperature range results in a reduced yield.
It has been found that dilute hydrochloric acid, e.g. 2 to 6N, preferably about 4N gives the highest yields of product. The amount of hydrochloric acid used is about 0.5 liter per mole of 4-fluoroaniline. Other strong acids such as sulfuric or phosphoric acid may also be used.
In the second step of the reaction, the mixture from step one is optionally filtered to remove any solid contaminants, then heated to reflux to convert the compounds of Formula il to a mixture
of 6-fluoroquinaldine and 6-fluoro
tetrahydroquinaldine. The presently preferred method of carrying out the heating step comprises the slow addition of the filtrate to refluxing toluene and allowing the water to azeotrope out of the reaction mixture. In this way the product is obtained as the solid hydrochloride salts which are easily collected, e.g., by filtration, and air-dried. Other azeotropes having a boiling point between about 90 and 1 200C such as water-acetic acid can also be used, but toiuene is preferred since a solid product is formed.
Alternatively, the reaction mixture of step one may be heated as is under reflux, or toluene may be added and then the mixture refluxed. The product mixture is then isolated after discarding the organic phase, by basifying, extracting (e.g., with toluene), drying, and precipitating as the salts by adding acid (e.g., by bubbling in gaseous
HCI). Optionally, after extraction and drying, the solvent (e.g., toluene) is removed in vacuo, a second solvent (e.g., acetone) is added, and the product precipitated as the salts by adding an acid.
For the reduction of step three, the dry solid is dissolved in a warm solution of isopropanol (about 1 ml per gram) and a weak acid such as acetic acid (about 1.0 ml per gram) and treated with a slight molar excess of a base such as ammonium acetate or triethylamine.
The mixture is cooled and the solid residue (ammonium chloride or triethylamine
hydrochloride) is removed e.g., by filtration. To the filtrate is added a platinum-based reducing
catalyst such as 5% platinum on carbon, about 10 to 20 g per mole, and the mixture is hydrogenated at a pressure of bout 30 to 70 psi at a temperature of 1 50C or less. The progress of the reaction is readily monitored by chromatographic
analysis. After completion of the reduction, the
catalyst and other residual solids are removed by filtration. The solvent is removed by evaporation and the residue is dissolved in a suitable solvent such as isopropanol. The solution is treated with anhydrous acid such as hydrogen chloride to precipitate 6-fluorotetrahydroquinaldine as the acid salt. Overall yields are typically 70 to 85% of this first crop.Further product is obtained by concentration of the isopropanol solution to increase the yield by 5 to 10%.
Alternatively, after reduction, filtration and evaporation, the product is isolated as the free base, e.g., by suspending in water and neutralizing with weak base such as aqueous ammonia.
Extraction (e.g., with toluene) followed by drying and evaporation provides 6-fiuoro- tetrahydroquinaldine. This product may be further purified by vacuum distillation if desired.
n the fourth step, condensation of 6-fluorotetrahydroquinaldine with a dialkyl diester of ethoxymethylenemalonate such as the diethyl ester is carried out byating the reactants without solvent at 100 to 200 C for about 1 to 5 hours or until the reaction is complete. The intermediate is an oil which need not be isolated or purified.
To carry out step five, polyphosphoric acid is added to the oil from step four and the solution (optionally diluted with toluene) is heated at 100 to 1 4O0C to effect cyclization to the ester of flumequine. The ester is hydrolyzed to the free acid by adding water followed by heating at reflux under the acid conditions. The isolation and purification of flumequine can be completed, e.g., by filtering to separate the solid product, followed by dissolving in sodium hydroxide solution and then precipitation with hydrochloric acid. The free base is optionally recrystallized from N,N dimèthylformamide.
The invention may be further illustrated by the following non-limiting examples.
Example 1
To a 10 gallon glass-lined Pfaudler reactor were added 20 liters of 4N hydrochloric acid, followed by 4-fluoroaniline (4,444.8 g, 40 moles).
The mixture was heated to 550C, and crotonaldehyde (3,463.3 g 85% aqueous soln., 42 moles) in methanol (3 liters) was added over 8 hrs. After the addition, the mixture was cooled to 200C and stirred overnight. The aqueous solution was pressure filtered through a 10 micron string filter, which was rinsed with 2 liters of water.
Total volume of the solution was about 31 liters.
The reactor was rinsed with water and acetone and dried with nitrogen. Toluene (20 liters) was added and brought to reflux (111 OC). The above aqueous solution was slowly added to the refluxing toluene, and the water resulting from the azeotrope was collected. Total time of addition was 5.7 hrs. The pot temperature decreased to 850C and stayed there during the first 6.7 hours of azeotroping. After this time, the mixture was cooled to 200C and stirred overnight. The next
morning, a solid precipitate was noted in the
reaction vessel. The azeotrope was continued.
After 4.5 hrs., pot temperature had slowly risen from 870C to 1000C. After an additional 0.5 hrs.,
pot temperature was steady at 111 OC and there was no visible azeotrope being formed. After an additional 0.5 hrs., the reaction mixture was cooled to 250C.
The solid was collected by filtration and rinsed with toluene (about 11 liters). The solid was sucked dry on a Buchner funnel for 22 hrs., followed by air drying an additional 42 hrs., yielding 7,535 g (93.5%) light brown solid. The solid was added to the dried 10 gallon reactor, along with isopropanol (8 liters) and acetic acid (6 liters). The mixture was stirred and heated to 700 C, followed by the addition of ammonium acetate (3,084 g, 40 moles). The mixture was stirred 1 5 minutes at 70-750C, cooled to 200C for 0.5 hr., and filtered. The reactor and filter cake were rinsed with isopropanol (4 liters). The white solid was air-dried to give ammonium chloride (1,904.7 g, 89% recovery based on the ammonium acetate added).The solution was then hydrogenated in the clean, dry
10 gallon reactor, using 5% platinum on carbon (640 g, 50% w/w). The temperature was kept at 1 50C and hydrogen applied at 50 psi until hydrogen uptake ceased (about 20 hours).
The reaction mixture was filtered (3 micron string filter), and rinsed with isopropanol (about 4 liters). The solution was re-added to the cleaned
10 gallon reactor and the solvent removed in vacuo (700, 27.5 inches vac). The resulting dark oil was redissolved in isopropanol (8 liters) and the solvent removed in vacuo to remove residual acetic acid. The residue was allowed to cool to 200C, dissolved in isopropanol (10 liters) and stirred overnight. This filtered solution was then added slowly (over 2-1/2 hrs.) to a solution of hydrogen chloride gas (1.75 kg, 48 moles) in isopropanol (16 liters). The resulting slurry was cooled to 1 20C, filtered, and rinsed twice with cold isopropanol (4 liters and 2 liters, respectively).The off-white solid was dried under vacuum (27 in) at 650 for 24 hrs., yielding 6fluorotetrahydroquinaldine hydrochloride (5,857.5 g, 72.7%).
The mother liquors were concentrated in vacuo, redissolved in 2 liters of hot isopropanol, cooled overnight, and the mixture filtered. The resulting dark solid was stirred with 1 liter of hot isopropanol, cooled, filtered and rinsed with isopropanol. The resulting off-white solid was dried, yielding 6-fluorotetrahydroquinaldehyde hydrochloride (254.0 g, 3.2%).
The resulting mother liquors were concentrated in vacuo to 1,380 g dark oil.
Analysis showed this was about 14% product, or
193 g, an additional 2.5% of product.
Example 2
Crotonaldehyde (93%, 79.13 g, 1.05 moles) in methanol (75 ml) was added to a solution of 4fluoro-aniline (111.12 g, 1 mole) in 4N hydrochloric acid (500 ml) over 3-1/2 hrs., at 550C+5. On completion of the addition, toluene (400 ml) was added, and the mixture was heated under reflux for 4 hrs. The mixture was cooled and the organic phase was discarded. The aqueous layer was basified with 50% sodium hydroxide solution (100 ml), to pH 11 and the liberated bases were extracted twice with toluene (400 ml and 200 ml, respectively).The combined toluene extracts were washed with water (300 ml) and the toluene solution dried by azeotropic distillation. toluene was removed by distillation, acetone (300 ml) was added, and the solution was cooled to below 200 C. This solution was treated with hydrogen chloride (36 g), keeping the temperature below 350C until it was acidic. After cooling the suspension at OOC for two hours, the product was collected, washed with acetone (200 ml) and dried in vacuo to 35 C to give a light brown solid. The mixture of hydrochlorides was isolated in 82% yield.
The mixture of hydrochlorides was suspended in acetic acid (50 ml) and isopropanol (100 ml) and heated with ammonium acetate (20 g) at 600C for 10 minutes. The precipitated ammonium chloride was removed by filtration and washed with isopropanol (25 ml). The filtrate was hydrogenated in the presence of 5% platinum on carbon catalyst (50% damp, 2 g) at an initial pressure of 60 psi.
Reaction was complete in 8-1 2 hrs. The catalyst was removed and the isopropanol in the filtrate was removed by evaporation.
Water (200 ml) was added, with cooling, and the solution was basified with ammonia solution (50 ml) to pH 9. The cooled solution was extracted twice with toluene (200 ml and 100 ml, respectively) and the combined organic layers were washed with water (300 ml). Finally, the toluene solution was dried by azeotropic distillation and the toluene was removed by evaporation under reduced pressure to give a dark brown oil which crystallized upon standing. Yield was about 93% of 6-fluorotetrahydroquinaldine.
The yield was 76% overall.
Example 3
6-Fluorotetrahydroquinaldine (12.05 kg containing 10% of toluene) and diethyl ethoxymethylene maionate (16.2 kg) were charged to a 225 liter Pfaudler reactor and heated at 12500 under vacuum for 4 hours. Ethanol (3.1 kg) was recovered. The product was cooled, diluted with toluene (35 liters) and tetraphosphoric acid (35 kg), reheated to reflux for 2 hours, cooled to 800C, diluted with water (128 liters) and refluxed for 6 hours to complete the hydrolysis. The crude flumequine was collected, washed acid free with water and rinsed with methanol. The damp cake was dissolved in sodium hydroxide solution (2.94 kg/59 liters) filtered hot through a cartridge filter heated to 900C and acidified with hydrochloric acid (6.64 liters). The product was collected, washed acid free, rinsed with methanol and dried in a vacuum oven. The yield of flumequine was 15.4 kg (90.8%). The dry solid was dissolved in N,Ndimethylformamide (70 liters) at 125 C, allowed to cool with stirring to 1000C then cooled to 70C with cold water. The product was collected, washed with methanol and dried as before. The yield of recrystallized flumequine was 14.4 kg (82.3%) overall.
Example 4
A mixture of 606 kg of diethyl ethoxymethylenemalonate and 400 kg of 6fluorotetrahydroquinaldine was stirred and heated at about 12500 for 5 hours. The mixture was cooled to about 950C and evaporated.
To the stirred reaction mixture was added 450 liters of toluene, then 908 kg of polyphosphoric acid at a rate to maintain a reaction temperature of 90 to 1000C. The mixture was then heated at reflux for fourteen hours.
To this mixture was added 950 liters of water over five hours. The ester was saponified by heating for 13 hours at 110 to 1 150C while removing the toluene via the toluene-water azeotrope. The solid product flumequine was separated by filtration, washed thrice with hot water, then with N,N-dimethylformamide.
Recrystallization form N,N-dimethyl-formamide gave white solid flumequine.
Alternatively, the water-washed flumequine was treated with ammonium hydroxide to dissolve it, decolorized, filtered, and then precipitated with concentrated hydrochloric acid.
Recrystallization provided white solid flumequine.
Claims (19)
1. A compound of the formula
wherein R is hydrogen or alkyl having one, two or three carbon atoms, or an acid addition salt thereof.
2. A compound according to claim 1 wherein R is hydrogen.
3. A compound according to claim 1 wherein R is methyl.
4. 64luoro-4-hydroxytetrahydro-quinaldine hydrochloride.
5. 6-fluoro-4-methoxytetrahydro-quinaldine hydrochloride.
6. A process for the preparation of flumequine comprising:
a. reacting 4-fluoroaniline with a reactant selected from the group consisting of crotonaldehyde, a precursor for crotonaldehyde which generates crotonaldehyde under acidic conditions, and an alcoholic solution of crotonaldehyde or said precursor for crotonaldehyde in the presence of dilute aqueous acid between about 50 and 600C to provide a compound of the formula
wherein R is hydrogen or alkyl having one, two or three carbon atoms;
b. heating the product of step a) to provide a mixture of 6-fluoroquinaldine and 6fluorotetrahydroquinaldine as acid salts;
c. treating said acid salts with base in the presence of weak acid followed by reducing the mixture to provide 6-fluorotetrahydroquinaldine;;
d. condensing said 6-fluorotetrahydroquinaldine with a dialkyl alkoxymethylenemalonate to provide a compound of the formula
e. cyclizing the product of step d) by heating in the presence of polyphosphoric acid followed by saponifying to provide flumequine.
7. The process according to claim 6 wherein said reactant in step a) is an alcoholic solution of crotonaldehyde.
8. The process according to claim 7 wherein said reactant in step a) is a methanolic solution of crotonaldehyde and said compound provided is
9. The process according to claim 6 wherein said dilute aqueous acid in step a) is hydrochloric.
.
10. The process according to claim 6 wherein said dialkyl alkyloxymethylenemalonate of step d) is diethylethoxymethylenemalonate.
11. A process for the preparation of 6fluorotetrahydroquinaldine comprising:
a. reacting 4-fluoroaniline with a reactant selected from the group consisting of crotonaldehyde, a precursor for crotonaldehyde which generates crotonaldehyde under acidic conditions, and an alcoholic solution of crotonaldehyde or said precursor for crotonaldehyde in the presence of dilute aqueous acid between about 50 and 600C to provide a compound of the formula
wherein R is hydrogen or alkyl having one, two or three carbon atoms;
b. heating the product of step a) in dilute acid to provide a mixture of 6-fluoroquinaldine and 6fluorotetrahydroquinaldine as acid salts;
c. treating said acid salts with base in the presence of weak acid followed by reducing the mixture to form 6-fluorotetrahydroquinaldine.
12. A process for the preparation of flumequine comprising:
a. reacting 4-fluoroaniline with a reactant selected from the group consisting of crotonaldehyde, a precursor for crotonaldehyde which generates crotonaldehyde under acidic conditions, and an alcoholic solution of crotonaldehyde or said precursor for crotonaldehyde in the presnce of dilute aqueous acid between about 50 and 600C to provide a compound of the formula
wherein R is hydrogen or alkyl having one, two, or three carbon atoms;
b. heating and removing water from the
product of step a) by slowly adding the product to a refluxing solvent which forms a binary azeotrope with water and has a boiling point between 900 and 1 200C to provide a mixture of 6 fluoroquinaldine and 6-fiuorotetrahydroquinaldine as acid salts;;
c. treating said acid salts with base in the presence of weak acid followed by reducing the mixture to provide 6-fluorotetrahydroquinaldine;
d. condensing said 6-fluorotetrahydroquinaldine with a dialkyl alkoxymethylenemalonate to provide a compound of the formula
13. The process of claim 12 wherein said solvent in step b) is toluene.
14. A process for the preparation of 6fluorotetrahydroquinaldine comprising:
a. reacting 4-fluoroaniline with a reactant selected from the group consisting of crotonaldehyde, a precursor for crotonaldehyde which generates crotonaldehyde under acidic conditions, and an alcoholic solution of crotonaldehyde or said precursor for crotonaldehyde in the presence of dilute aqueous acid between about 50 and 600C to provide a compound of the formula
wherein R is hydrogen or alkyl having one, two or three carbon atoms;
b. heating and removing water from the product of step a) by slowly adding the product to a refluxing solvent which forms a binary azeotrope
with water and has a boiling point between 900 and 1 ?00C to provide a mixture of 6fluoroquinaldine and 6-fluorotetrahydroquinaldine as acid salts; ;
c. treating said acid salts with base in the presence of weak acid followed by reducing the mixture to form 6-fluorotetrahydroquinaldine.
1 5. The process according to claim 14 wherein said solvent of step b) is toluene.
16. A compound according to claim 1 substantially as hereinbefore described in any one of the Examples.
1 7. A process for the preparation of flumequine, the process being substantially as hereinbefore described in Example 3 or 4.
1 8. A process for the preparation of 6fluorotetrahydroquinaldine, or a salt thereof, the process being substantially as hereinbefore described in Example 1 or 2.
19. A process for the preparation of a compound according to claim 1, the process being substantially as hereinbefore described.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/122,470 US4301291A (en) | 1980-02-19 | 1980-02-19 | Intermediates for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid |
US06/122,657 US4301289A (en) | 1980-02-19 | 1980-02-19 | Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid |
US06/122,599 US4301288A (en) | 1980-02-19 | 1980-02-19 | Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2069498A true GB2069498A (en) | 1981-08-26 |
GB2069498B GB2069498B (en) | 1984-02-08 |
Family
ID=27382802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8105054A Expired GB2069498B (en) | 1980-02-19 | 1981-02-18 | Substituted tetrahydroquinaldines intermediates for 6,7-dihydro-9-flouro-5-methyl-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic acid |
Country Status (6)
Country | Link |
---|---|
JP (2) | JPH0215066A (en) |
AU (1) | AU524459B2 (en) |
FR (1) | FR2476079A1 (en) |
GB (1) | GB2069498B (en) |
IE (1) | IE50928B1 (en) |
NZ (1) | NZ196293A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0079162A1 (en) * | 1981-11-06 | 1983-05-18 | Riker Laboratories, Incorporated | Derivatives of 8-amino and 8-aminomethyl benzo(ij)quinolizine |
EP0119779A1 (en) * | 1983-03-17 | 1984-09-26 | Riker Laboratories, Incorporated | 8-Alkoxy-6,7-dihydro-5-methyl-9-fluoro-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acids |
EP0161482A1 (en) * | 1984-04-11 | 1985-11-21 | Roche Diagnostics GmbH | Fluorinated aniline derivatives and their use |
EP0310849A1 (en) * | 1987-10-05 | 1989-04-12 | S P A SOCIETA' PRODOTTI ANTIBIOTICI S.p.a. | Process for the synthesis of a benzo [ij] quinolizine-2-carboxylic acid derivative |
EP0385271A1 (en) * | 1989-02-27 | 1990-09-05 | Eastman Kodak Company | Tetrahydroquinolines and method of preparation |
US5043469A (en) * | 1989-07-17 | 1991-08-27 | Eastman Kodak Company | Process for preparing 5-substituted aminophenols |
WO2002022585A1 (en) * | 2000-09-14 | 2002-03-21 | Kaken Pharmaceutical Co., Ltd. | Tetrahydroquinoline compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE793524A (en) * | 1971-12-30 | 1973-06-29 | Riker Laboratories Inc | BENZOQUINOLIZINE-CARBOXYLIC ACIDS AND THEIR DERIVATIVES |
ZA728444B (en) * | 1971-12-30 | 1973-10-31 | Riker Laboratories Inc | Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof |
-
1981
- 1981-02-18 GB GB8105054A patent/GB2069498B/en not_active Expired
- 1981-02-18 IE IE326/81A patent/IE50928B1/en not_active IP Right Cessation
- 1981-02-18 NZ NZ196293A patent/NZ196293A/en unknown
- 1981-02-18 FR FR8103180A patent/FR2476079A1/en active Granted
- 1981-02-18 AU AU67425/81A patent/AU524459B2/en not_active Ceased
-
1989
- 1989-05-01 JP JP1112745A patent/JPH0215066A/en active Granted
- 1989-05-01 JP JP1112746A patent/JPH0215077A/en active Granted
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0079162A1 (en) * | 1981-11-06 | 1983-05-18 | Riker Laboratories, Incorporated | Derivatives of 8-amino and 8-aminomethyl benzo(ij)quinolizine |
EP0119779A1 (en) * | 1983-03-17 | 1984-09-26 | Riker Laboratories, Incorporated | 8-Alkoxy-6,7-dihydro-5-methyl-9-fluoro-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acids |
EP0161482A1 (en) * | 1984-04-11 | 1985-11-21 | Roche Diagnostics GmbH | Fluorinated aniline derivatives and their use |
US4912258A (en) * | 1984-04-11 | 1990-03-27 | Boehringer Mannheim Gmbh | Fluorinated aniline derivatives and their use |
EP0310849A1 (en) * | 1987-10-05 | 1989-04-12 | S P A SOCIETA' PRODOTTI ANTIBIOTICI S.p.a. | Process for the synthesis of a benzo [ij] quinolizine-2-carboxylic acid derivative |
EP0385271A1 (en) * | 1989-02-27 | 1990-09-05 | Eastman Kodak Company | Tetrahydroquinolines and method of preparation |
US5043469A (en) * | 1989-07-17 | 1991-08-27 | Eastman Kodak Company | Process for preparing 5-substituted aminophenols |
WO2002022585A1 (en) * | 2000-09-14 | 2002-03-21 | Kaken Pharmaceutical Co., Ltd. | Tetrahydroquinoline compounds |
JPWO2002022585A1 (en) * | 2000-09-14 | 2004-01-22 | 科研製薬株式会社 | Tetrahydroquinoline compound |
US6777427B2 (en) | 2000-09-14 | 2004-08-17 | Kaken Pharmaceutical Co., Ltd. | Tetrahydroquinoline compounds |
Also Published As
Publication number | Publication date |
---|---|
FR2476079B1 (en) | 1984-04-20 |
IE810326L (en) | 1981-08-19 |
NZ196293A (en) | 1983-09-02 |
JPH0416474B2 (en) | 1992-03-24 |
FR2476079A1 (en) | 1981-08-21 |
AU6742581A (en) | 1981-09-24 |
IE50928B1 (en) | 1986-08-20 |
JPH0215077A (en) | 1990-01-18 |
JPH0375541B2 (en) | 1991-12-02 |
AU524459B2 (en) | 1982-09-16 |
GB2069498B (en) | 1984-02-08 |
JPH0215066A (en) | 1990-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108658858B (en) | Preparation and refining method of hydroxychloroquine and preparation method of sulfate thereof | |
KR870001944B1 (en) | Method for preparing quinoline carboxylic acid derivative | |
GB2069498A (en) | Substituted- tetrahydroquinaldines, intermediates for 6,7-dihydro-9- fluoro-5-methyl-1-oxo-1H,5H- benzo(ij)quinolizine-2-carboxylic Acid | |
US4301289A (en) | Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid | |
WO2000062782A1 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
US4301291A (en) | Intermediates for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid | |
IL39729A (en) | Pyridine derivatives | |
US4301288A (en) | Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid | |
US6576764B2 (en) | Synthesis and crystallization of piperazine ring-containing compounds | |
EP0449172B1 (en) | A method of reducing a carbonyl containing acridine | |
EP0906906B1 (en) | Process for preparing optically active 2-piperazinecarboxylic acid derivatives | |
CN109956899B (en) | Preparation method of vitamin B6 | |
WO1995023787A1 (en) | Process for producing 5,7-dichloro-4-hydroxyquinoline | |
JP3291987B2 (en) | Purification method of O, S-dimethyl-N-acetylphosphoramidothioate | |
US4758679A (en) | Preparation of 7-(3-(propylamino)-2-hydroxypropoxy)flavone | |
FI91749C (en) | Process for the preparation of quinoline carboxylic acid derivatives | |
Foster et al. | Some γ-Substituted Benzoquinoline Derivatives1 | |
EP0285655B1 (en) | Process for the preparation of quinoline-carboxylic acid derivatives | |
JP3471045B2 (en) | Method for producing high-purity quinophthalone dicarboxylic acid | |
KR100228919B1 (en) | Process for preparation of benzophenone derivatives | |
CA1326239C (en) | Preparation of ciprofloxacin | |
US4806643A (en) | Preparation of riboflavin | |
KR960011385B1 (en) | Method for preparing quinolone derivative | |
EP0482607A1 (en) | Process of producing 2-aminothiazole | |
JPS6213936B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19980218 |